MedLife, the leader of the private medical services market in Romania, posts a consolidated pro-forma turnover of EUR 453 mln, up by 25% compared to 2022
The systematic, non-opportunistic construction of the largest medical network in Romania brought significant advantages in terms of notoriety and trust in the brand, generating an important organic growth of 12%, which seems to be…
- The systematic, non-opportunistic construction of the largest medical network in Romania brought significant advantages in terms of notoriety and trust in the brand, generating an important organic growth of 12%, which seems to be maintained in the first two months of the current year, thus creating strong growth premises for the rest of the year.
- The company records a 25% increase in consolidated pro-forma turnover, simultaneously with a gradual increase in EBITDA margins compared to last year, a trend it intends to maintain.
- The investments in medical oncology, top equipment, the launch of the transport of biological samples with drones and, last but not least, the equipping of three hospitals with state-of-the-art surgical robots, place MedLife at the forefront of medical technology not only in Romania, but also in the region.
MedLife (BVB ticker: M), the largest network of private medical services in Romania and the only Romanian capital company among the top operators of private medical services listed on the Stock Exchange, reports a consolidated pro-forma turnover of RON 2.24 billion, up by 25% compared to the previous year, maintaining this growth trend since listing until now. At the same time, MedLife managed to gradually recover a large part of its lost margins thanks to the investments from the last years.
The company invested in technology at an unprecedented level, opening at the end of last year a large hospital in Bucharest, Provita-Nord, modernized and gradually expanded the Medical Park hospital in Bucharest, invested in new radiotherapy clinics in Braila and Valcea, invested in three new surgical robots in different locations in the country and, for the first time in Central and Eastern Europe, started the transportation by drones for biological samples. Thus, MedLife marked its leading position in medical technology not only in Romania, but probably also in the region.
According to MedLife representatives, almost all business lines continued their upward trend in 2023, highlighting the excellence and high quality services provided in clinics, hospitals and the corporate area, which recorded increases of 35%, 27% and 17%, respectively , followed by laboratories and dental clinics with increases of 15% and 2%, while pharmacies saw a decrease as a result of the adjustments of the drugs’ portfolio for a more efficient operational management. These performances are supported by steady growth in all areas of the country, although inflation remains high and consumer costs continue to rise.
